SFA — Sopharma AD Cashflow Statement
0.000.00%
Last trade - 00:00- BGN971.56m
- BGN1.34bn
- BGN2.14bn
- 29
- 74
- 75
- 64
Annual cashflow statement for Sopharma AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -134 | -148 | -145 | -170 | -206 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -179 | -76 | 110 | 45 | 76.6 |
| Capital Expenditures | -27 | -27.1 | -23.7 | -43.3 | -121 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 28.5 | -41 | -40 | -19.6 | 33.1 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 1.5 | -68.1 | -63.6 | -62.8 | -87.7 |
| Financing Cash Flow Items | 243 | 204 | 30.6 | -0.513 | 4.85 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 176 | 157 | -64.3 | 127 | -81.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.22 | 12.6 | -17.9 | 109 | -92.9 |